CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

L-carnitine

Novel & Emerging BiomarkersLab test / biomarkerriskpartially modifiable
11
evidence score

Also known as: plasma L-carnitine, plasma L-carnitine levels

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 3meta-analyses: 0trials: 7.8genetic: 0MR bonus:

References (1)

0 meta-analyses / systematic reviews

Clinical trials (5)

NCTTitleStatusTypeInterventions
NCT07249229Investigating the Effect of Oral L-Carnitine on Inflammatory and Nutritional Factors in Patients With Advanced Kidney Failure Undergoing Chronic HemodialysisCOMPLETEDINTERVENTIONALL-carnitine 1000 Mg, Placebo
NCT02117661ECoM Study: Effect of Carnitine Supplementation on Progression of Carotid Plaque in the Metabolic Syndrome.COMPLETEDINTERVENTIONALL-carnitine capsules, Cellulose capsules
NCT00822172Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent ClaudicationCOMPLETEDINTERVENTIONALLevocarnitine tartrate, cilostazol
NCT00984750A Prospective, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effect of 6-month Acetylcarnitine Therapy on Arterial Blood Pressure, Lipid and Metabolic Profile, and Kidney Function in Hypertensive Patients With Type 2 Diabetes on Background Simvastatin TherapyCOMPLETEDINTERVENTIONALacetyl-L-carnitine/statin (simvastatin), placebo
NCT00399919Safety and Efficacy pf Propionyl-L-Carnitine in Combination With Monitored Exercise Training in Peripheral Arterial Disease (Intermittent Claudication).COMPLETEDINTERVENTIONALPropionyl-L-Carnitine, PLC

Genetic associations (0)

None linked.